Inhibitors of Adaptor-Associated Kinase 1 (AAK1) May Treat Neuropathic Pain, Schizophrenia, Parkinson’s Disease, and Other Disorders

AAK1 was identified as a potential therapeutic target for the treatment of neuropathic pain. Recent research has shown that AAK1 knockout mice exhibit a high resistance to pain. Therefore, the inhibition of AAK1 may be beneficial in treating neuropathic pain